1:07 PM
Oct 11, 2018
 |  BC Extra  |  Company News

Management tracks: Former Baxalta exec joins VisionGate; Carrick names Golumbeski chair

Cancer company VisionGate Inc. (Phoenix, Ariz.) hired John Glasspool as chief operating and strategy officer, a newly created position. He was EVP and head of corporate strategy and customer operations at Baxalta Inc., which Shire plc (LSE:SHP; NASDAQ:SHPG) acquired in 2016.

Cancer company Carrick Therapeutics Ltd. (Dublin, Ireland) appointed George Golumbeski as chairman. He is president of early cancer detection company Grail Inc. (Menlo Park, Calif.). He was also an EVP at Celgene Corp. (NASDAQ:CELG), where he led the company's business development.

Neurology company Revance Therapeutics Inc. (NASDAQ:RVNC) hired Tobin Schilke as CFO, effective Nov. 5. He succeeds CFO and CBO Lauren Silvernail, who left in May. Schilke was CFO at Achaogen Inc. (NASDAQ:AKAO).

Merck & Co. Inc. (NYSE:MRK) hired Nicholas Haining as VP of oncology for discovery, preclinical and early development, effective January 2019. He is an associate professor of pediatric oncology at Dana-Farber Cancer Institute, associate professor of pediatrics at Harvard Medical School and associate member at the Broad Institute of MIT and Harvard.

Drug delivery and cannabinoid company Insys Therapeutics Inc. (NASDAQ:INSY) hired Mark Nance as its chief legal officer and general counsel. He was general counsel at Mylan N.V. (NASDAQ:MYL).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD